GL1X · GenesisL1 explorer

MolNFT v1 · #120434 · protein

Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor (S)-ETHYL2-(((1R,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-PYRROLO[2,3- D]PYRIMIDIN-7-YL)CYCLOHEXYL)AMINO)-4-methylpentanoate

5H09 · Tyrosine-protein kinase hck: “Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor…”. X-ray diffraction, 1 ligand (OOO), 3 pockets (best druggability 0.72). MolNFT v1 #120434 on GenesisL1: 3D structure, binding…

PDB
5H09
Type
protein
Length
447 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase hck
EC
2.7.10.2
UniProt
P08631
Ligands
OOO
Pockets
3 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase hck (EC 2.7.10.2)protein44730% helix, 21% strandP08631

Ligands and binding sites

  • OOO · ethyl (2~{S})-2-[[4-[4-azanyl-5-(4-phenoxyphenyl)pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexyl]amino]-4-methyl-pentanoate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110810.720.7692empty
24240.720.8241OOO
31570.540.8024empty

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 5H09 · Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00
  • P08631 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase hck (P08631) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.